CN Patent
CN113143950B — 一种治疗肝病的药物组合物及其应用
Assigned to Second Hospital of Hebei Medical University · Expires 2023-04-18 · 3y expired
What this patent protects
本发明提供了一种药物组合物,活性成分由奥贝胆酸、冰片或奥贝胆酸、冰片、甲钴胺组成。所述药物组合物可以用于制备治疗非酒精性脂肪肝炎药物,且能够较少奥贝胆酸引发的瘙痒。
USPTO Abstract
本发明提供了一种药物组合物,活性成分由奥贝胆酸、冰片或奥贝胆酸、冰片、甲钴胺组成。所述药物组合物可以用于制备治疗非酒精性脂肪肝炎药物,且能够较少奥贝胆酸引发的瘙痒。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.